Literature DB >> 26899495

A Case of a Bilateral Inflammatory Breast Cancer: A Case Report.

James Kurtz1, Deepa Halaharvi1, Shakir Sarwar1, Mark Cripe1.   

Abstract

Cases of bilateral inflammatory breast cancer (IBC) are extremely rare. Our search criteria only found one other record of metachronous bilateral IBC (1). We present the case of a patient who was treated for IBC with neoadjuvant chemotherapy, modified radical mastectomy (MRM), and whole breast radiation. Less than 1 year later, the patient had a recurrence of IBC on the left chest wall with in the radiated field, as well as a new IBC on the contralateral side. Bilateral IBC is extremely rare. This entity can present challenges for the standard treatment of IBC with neoadjuvant chemotherapy, MRM, and whole breast radiation (2). Our case study shows the importance of scheduled routine imaging, screening with physical examination after IBC management, and good patient compliance in this aggressive disease (3).
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  contralateral inflammatory breast cancer; inflammatory breast cancer; locally advanced breast cancer

Year:  2016        PMID: 26899495     DOI: 10.1111/tbj.12578

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  3 in total

1.  Idiopathic gigantomastia in a patient on polypharmacy.

Authors:  Ngoc-Nhu Jennifer Nguyen; Lilia Maria Sanchez; Mariam Yassa; Julie David; Mona El Khoury
Journal:  BJR Case Rep       Date:  2021-06-09

2.  Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer.

Authors:  Yuta Kawaguchi; Sayaka Kuba; Michi Morita; Xiangyue Meng; Hiroko Hayashi; Kazuma Kobayashi; Tomohiko Adachi; Masaaki Hidaka; Shinichiro Itoh; Kengo Kanetaka; Susumu Eguchi
Journal:  Intern Med       Date:  2022-01-13       Impact factor: 1.282

3.  Gonococcal epididymo-orchitis in an octogenarian.

Authors:  Ali Ahmad; Halina Kusz
Journal:  J Community Hosp Intern Med Perspect       Date:  2020-08-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.